Presentation is loading. Please wait.

Presentation is loading. Please wait.

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith.

Similar presentations


Presentation on theme: "National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith."— Presentation transcript:

1 National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith M. Kramer, MD, MS, Bradley Hammill, MA, Kevin J. Anstrom, PhD, Donald Fetterolf, MD, MBA, Richard Snyder, MD, John P. Charde, MD, Barbara S. Hoffman, PA-C, MBA, Nancy Allen LaPointe, PharmD, Eric Peterson, MD, MPH  American Heart Journal  Volume 152, Issue 3, Pages 454.e1-454.e8 (September 2006) DOI: /j.ahj Copyright © 2006 Mosby, Inc. Terms and Conditions

2 Figure 1 National adherence by cumulative time intervals.
American Heart Journal  , 454.e1-454.e8DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions

3 Figure 2 National adherence for cumulative time intervals by health plan product for patients aged 35 to 64 (A) and ≥65 years (B). American Heart Journal  , 454.e1-454.e8DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions

4 Figure 3 Adherence over 360 days by region and product. Kruskall-Wallis test: All patients: P < ; Medicare + Choice: P = 0.04. American Heart Journal  , 454.e1-454.e8DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions


Download ppt "National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith."

Similar presentations


Ads by Google